Abstract
There are limited data on fetuin-A, soluble leptin receptor (sOB-R) and free leptin index (FLI) in patients with chronic lymphocytic leukemia (CLL). The aim of this study was to compare circulating fetuin-A, sOB-R levels and FLI between 95 patients with CLL and 95 matched controls, as well as among different stages of CLL. Circulating fetuin-A was significantly lower in cases than controls (241.9 ± 99.2 vs. 288.8 ± 127.7 μg/mL; p = 0.005). Although circulating sOB-R levels were similar between groups, FLI was lower in cases than controls (0.45 ± 0.42 vs. 0.67 ± 0.57; p = 0.003). Furthermore, lower fetuin-A or FLI, but not sOB-R, were independently associated with CLL (p < 0.05), particularly among overweight/obese individuals. Fetuin-A, s-OB-R and FLI were similar between different stages of CLL severity, or between symptomatic and asymptomatic disease. In conclusion, circulating fetuin-A and FLI, but not sOB-R, were lower in patients with CLL than controls, a finding warranting further investigation.
References
Nov 1, 1991·Annals of Hematology·L KalabayL Jakab
Jul 1, 1981·Cancer·J L BinetF Gremy
Jan 22, 2000·Annals of Oncology : Official Journal of the European Society for Medical Oncology·N L HarrisC D Bloomfield
Jun 16, 2004·European Journal of Cancer Care·A RedaelliC L Pashos
Sep 4, 2004·Experimental Hematology·Jae-Yong KwakYong-Geun Kwak
Jan 25, 2008·Blood·Michael HallekUNKNOWN International Workshop on Chronic Lymphocytic Leukemia
May 9, 2009·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Jae Kyo YiDong-Young Noh
May 11, 2010·Cancer Causes & Control : CCC·Maria DalamagaChristos S Mantzoros
Jul 21, 2010·Proceedings of the National Academy of Sciences of the United States of America·Queenie Lai Kwan LamLiwei Lu
Aug 19, 2010·Journal of Clinical Gastroenterology·Stergios A PolyzosGeorgia Deretzi
Nov 23, 2010·Cellular Signalling·Anton-Scott Goustin, Abdul B Abou-Samra
Jun 9, 2011·Leukemia & Lymphoma·Clive S Zent, Neil E Kay
Jul 27, 2011·Clinics·Stergios A PolyzosGeorgia Deretzi
Sep 29, 2011·International Journal of Cancer. Journal International Du Cancer·Paul DowlingMartin Clynes
Nov 15, 2011·Recent Patents on Endocrine, Metabolic & Immune Drug Discovery·Katsuhito MoriMasaaki Inaba
Oct 17, 2012·Clinical Endocrinology·Kyung Mook ChoiKyung Wan Min
Nov 14, 2012·The Journal of Pharmacy and Pharmacology·Monika SinghNikhlesh Kumar
Mar 12, 2013·Endocrine Reviews·Hyun-Seuk MoonChristos S Mantzoros
Mar 14, 2013·Leukemia & Lymphoma·Richard RosenquistRebeqa Gunnarsson
Apr 10, 2013·Proteome Science·Pavel MájekJan E Dyr
Jun 19, 2013·Cell Metabolism·Maria DalamagaChristos S Mantzoros
Oct 22, 2013·Metabolism: Clinical and Experimental·Maria DalamagaChristos S Mantzoros
Jan 21, 2014·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Krasimira AleksandrovaTobias Pischon
Oct 28, 2014·Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals·Maria DalamagaChristos S Mantzoros
Dec 3, 2014·Metabolism: Clinical and Experimental·Stergios A PolyzosChristos S Mantzoros
Dec 3, 2014·JAMA : the Journal of the American Medical Association·Chadi Nabhan, Steven T Rosen
Dec 4, 2014·Metabolism: Clinical and Experimental·Claudio ProcacciniGiuseppe Matarese
Jan 7, 2015·CA: a Cancer Journal for Clinicians·Rebecca L SiegelAhmedin Jemal
Apr 29, 2015·Biomedical Papers of the Medical Faculty of the University Palacký, Olomouc, Czechoslovakia·Anna Maria DabrowskaDariusz Duma